鼻咽癌放疗后脑坏死幸存者认知功能障碍的进展:一项前瞻性队列研究
基于一项进行中的前瞻性队列研究,纳入134例完成3年随访且至少接受两次认知评估的鼻咽癌放疗后脑坏死患者,使用中文版蒙特利尔认知评估(MoCA)评估认知状态,线性混合效应模型分析MoCA总分及7个分项的年进展率。中位随访2.35年期间,由正常转为轻度/中度认知功能障碍的转移概率分别为14.2%(19/134)和1.49%(2/134);MoCA总分每年下降-0.569分(SE 0.208,p=0.008)。放疗至脑坏死间隔≤6年的患者总分年进展率更高[-0.851(SE 0.321),p=0.013;交互作用p=0.041]。
要点
- 中位随访2.35年,由正常转为轻度认知功能障碍的转移概率为14.2%(19/134)。
- MoCA总分每年下降-0.569分(SE 0.208,p=0.008)。
- 放疗至脑坏死间隔≤6年者总分年进展率更高(交互作用p=0.041)。
核心结论
- 鼻咽癌放疗后脑坏死患者认知功能随时间的年下降率,尤其对放疗后快速发生脑坏死者,对预防或减轻认知下降的临床试验患者选择和样本量计算有重要意义。
研究设计与样本
- 基于一项进行中的前瞻性队列研究,纳入年龄≥18岁、诊断为放疗后脑坏死的鼻咽癌患者,要求完成3年随访框架且至少接受两次认知评估,共134例。
主要发现
- 中位随访2.35年期间,由正常转为轻度认知功能障碍的转移概率为14.2%(19/134),转为中度认知功能障碍的转移概率为1.49%(2/134)。
- MoCA总分每年下降-0.569分(SE 0.208,p=0.008)。
- 放疗至脑坏死间隔≤6年的患者MoCA总分年进展率为-0.851(SE 0.321,p=0.013;交互作用p=0.041)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The evidence of longitudinal changes in cognition in nasopharyngeal carcinoma (NPC) survivors with radiation-induced brain necrosis (RIBN) after radiotherapy (RT) remained insufficient. We aimed to estimate the clinical progression rate of cognitive decline and identify patients with differential decline rates. MATERIALS AND METHODS: Based on an ongoing prospective cohort study, NPC patients aged ≥18 years old and diagnosed with RIBN were included in this current analysis if they finished the time frame of 3-year follow-up and had at least twice cognition assessments. The Chinese version of the Montreal Cognitive Assessment (MoCA) was used to assess the cognitive state. Linear mixed-effect models were used to analyze the annual progression rates of MoCA total and seven sub-items scores. RESULTS: Among 134 patients in this study, the transition probability from normal to mild/moderate cognitive dysfunction were 14.2 % (19/134) and 1.49 % (2/134) respectively during the median follow-up time of 2.35 years. The total MoCA score declined by -0.569 (SE 0.208) points annually (p = 0.008). Patients with ≤6 years of duration from RT to RIBN have higher annual progression rate of total scores [-0.851 (SE 0.321), p = 0.013; p for interaction = 0.041]. CONCLUSION: Our findings of the annual decline rate of cognition in NPC patients with RIBN from a 3-year longitudinal data, particularly for those who developed RIBN rapidly after RT, have important implications for the upcoming clinical trials designed to prevent or decrease cognitive decline in NPC patients with RIBN, regarding the selection of study patients and the calculation of sample size.
引用
- Zhu Y, Cheng J, Li Y, et al. Progression of cognitive dysfunction in NPC survivors with radiation-induced brain necrosis: A prospective cohort. Radiother Oncol. 2023. PMID: 38030079. doi:10.1016/j.radonc.2023.110033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。